Novartis reports $14.5 billion Q3 sales
NVSUSD
Statements (7)
- Bullish
Novartis has raised its third-quarter earnings guidance.
- Bullish
Novartis raises its earnings forecast following a strong fourth-quarter result.
- Bullish
Novartis raised its financial guidance despite setbacks in clinical trials
- Neutral
Novartis backed its sales outlook.
- Neutral
Novartis reported revenue of $14.5 billion in the third quarter of 2026
- Bullish
Novartis raises profit outlook on growth of new medicines
- Neutral
Novartis AG reported third-quarter net sales of $14.5 billion for fiscal year 2026.